Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

Continuous Glucose Monitoring (CGM) to Assess Hypoglycemia in Older Adults With Diabetes in Long Term Care (LTC) Facilities

To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications).

This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.

Inclusion Criteria:

• Adults >64 years with diagnosis of type 1 or type 2 diabetes
• Using glucose-lowering medication or insulin

Exclusion Criteria:

• Currently taking or planning to take hydroxyurea
• Patient or Health care proxy refuses to sign consent form